$9.31B
$897,000
0.0% of portfolio
39
Q1 2025
Reduced 81.07%
$54.5B
$30 Million
0.0% of portfolio
160
Q3 2025
Reduced 10.11%
Bioline Rx Limited Sponsored Adr (Israel)
-
$945,000
0.0% of portfolio
-
Q2 2025
Reduced 16.67%
$30.3B
$27.7 Million
0.0% of portfolio
383
Q4 2024
Reduced 24.75%
$20B
$26.2 Million
0.0% of portfolio
310
Q2 2025
Added 18.32%
$0
$29.1 Million
0.0% of portfolio
703
Q3 2025
New
-
$50.1 Million
0.0% of portfolio
-
Q2 2025
New
$3.74B
$4.21 Million
0.0% of portfolio
104
Q1 2025
Added 4.0%
$6.29B
$164,000
0.0% of portfolio
6
Q3 2025
New
$0
$1.07 Million
0.0% of portfolio
20
Q2 2023
New
$0
$574,000
0.0% of portfolio
11
Q3 2025
Reduced 94.66%
$4.44B
$12.2 Million
0.0% of portfolio
98
Q2 2023
New
$27.2B
$43.5 Million
0.0% of portfolio
200
Q2 2023
New
$8.76B
$13.8 Million
0.0% of portfolio
855
Q3 2025
New
$28.3B
$34.7 Million
0.0% of portfolio
423
Q3 2023
Reduced 33.07%
-
$2.12 Million
0.0% of portfolio
-
Q4 2024
New
$38.4B
$3.83 Million
0.0% of portfolio
150
Q3 2025
Added 108.33%
$32B
$875,000
0.0% of portfolio
5
Q1 2025
Reduced 37.5%
$61.6B
$793,000
0.0% of portfolio
28
Q4 2024
New
$161B
$44.2 Million
0.0% of portfolio
41
Q4 2024
Added 36.67%
$30.4B
$260,000
0.0% of portfolio
10
Q3 2025
Reduced 92.91%
$47.8B
$1.15 Million
0.0% of portfolio
17
Q4 2024
New
$0
$6.58 Million
0.0% of portfolio
125
Q3 2025
Added 62.34%
$0
$3.22 Million
0.0% of portfolio
30
Q3 2025
Added 1,400.0%
$0
$3.62 Million
0.0% of portfolio
33
Q3 2025
Added 3.13%
$0
$23.3 Million
0.0% of portfolio
120
Q1 2024
Added 60.0%
$0
$42.3 Million
0.0% of portfolio
397
Q4 2024
Reduced 15.89%
$0
$16.4 Million
0.0% of portfolio
520
Q4 2023
Reduced 36.27%
$0
$20.2 Million
0.0% of portfolio
43
Q4 2024
Added 26.47%
$0
$10.4 Million
0.0% of portfolio
51
Q2 2025
Reduced 15.0%
$0
$707,000
0.0% of portfolio
4
Q2 2025
Reduced 71.43%
$0
$7.27 Million
0.0% of portfolio
51
Q2 2023
New
$0
$4.19 Million
0.0% of portfolio
30
Q2 2025
Reduced 16.67%
$0
$379,000
0.0% of portfolio
1
Q2 2025
Reduced 75.0%
$0
$36.3 Million
0.0% of portfolio
176
Q3 2025
Added 0.57%
$0
$20.5 Million
0.0% of portfolio
144
Q2 2023
New
$0
$37.1 Million
0.0% of portfolio
602
Q2 2025
Reduced 0.66%
$5.83B
$7.33 Million
0.0% of portfolio
244
Q4 2023
Reduced 5.79%
$745M
$680,000
0.0% of portfolio
7
Q2 2025
New
$1.38B
$1.22 Million
0.0% of portfolio
214
Q2 2025
New
Net Lease Office Properties Reit
-
$721,000
0.0% of portfolio
-
Q3 2025
Added 9.09%
$4.89B
$718,000
0.0% of portfolio
100
Q2 2023
New
$79.2B
$7.18 Million
0.0% of portfolio
103
Q3 2025
Reduced 29.93%
$37.7B
$26.9 Million
0.0% of portfolio
5,600
Q2 2023
New
$65.7B
$30.7 Million
0.0% of portfolio
102
Q3 2025
Reduced 25.0%
$26.6B
$1.35 Million
0.0% of portfolio
10
Q4 2024
New
$109B
$9.02 Million
0.0% of portfolio
163
Q3 2025
Reduced 99.1%
$954M
$25.2 Million
0.0% of portfolio
700
Q3 2025
New
$15.2B
$19.4 Million
0.0% of portfolio
261
Q4 2024
New
$39.8B
$15.5 Million
0.0% of portfolio
329
Q3 2025
Added 0.3%